Prophylactic aciclovir (oral or intravenous) vs placebo
Recurrence of lesions · Patients being treated for cancer (predominantly haematological malignancies)
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer 2009 · Cochrane All outcomesRecurrence of lesions was a planned secondary outcome; no included trial reported data for this outcome in the prophylactic aciclovir versus placebo comparison.0 studiesNo studies found